α-Synuclein expression is required for somatodendritic dopamine release and immediate early gene induction
Science Advances · 30.01.2026 · 12 (5)
DOI: 10.1126/sciadv.ady6978 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, erschienen am 30.01.2026. Verfasst von Se Joon Choi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Molecular Therapeutics, New York State Psychiatric Institute, RFMH, New York, NY, USA. Hauptthemen laut MEDLINE: alpha-Synuclein, Dopamine, Genes, Immediate-Early, Dendrites. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, NIA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
α-Synuclein (αSyn) is a presynaptic protein of unestablished physiological function that plays a central role in Parkinson’s disease neuropathology. To date, the reported effects of αSyn expression on the kinetics of axonal synaptic vesicle exocytosis and membrane cycling have been relatively small. In contrast, we report that αSyn is the major modulator of substantia nigra somatodendritic dopamine release, a little-understood form of neurotransmission that is central to sensorimotor and basal ganglia circuitry. This regulation is due to a previously unknown role for αSyn in controlling the activity of the L-type calcium ion channels (LTCC), which are also implicated in Parkinson’s pathogenesis. αSyn-deficient neurons further display decreased spike frequency adaptation, hippocampal LTCC-dependent long-term potentiation, and immediate early gene induction, functions that are essential for synaptic adaptation and neuronal plasticity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Molecular Therapeutics, New York State Psychiatric Institute, RFMH, New York, NY, USA.
- Department of Psychiatry, Columbia University Medical Center, New York, NY, USA.
- Department of Physiology and Cellular Biophysics, Columbia University Medical Center, New York, NY, USA.
- Department of Neurology, Columbia University Medical Center, New York, NY, USA.
- Ann Romney Center for Neurologic Diseases, Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115.
- Department of Pharmacology, Columbia University Medical Center, New York, NY, USA.
ORCID-Profile: Se Joon Choi, Manu Ben-Johny, Guomei Tang, Jonas Bendig, Benjamin D Hobson, Nagendran Ramalingam, Ulf Dettmer, Ellen Kanter, David Sulzer, Eugene V Mosharov
Förderung
- NINDS NIH HHS
- NIA NIH HHS
- NCI NIH HHS
- NIDA NIH HHS
- National Institutes of Health
- National Institute on Drug Abuse
- National Institute of Health Sciences
- The Freedom Together Foundation
Zitieren
APA
Choi, S. J., Frank, A., Ben-Johny, M., Tang, G., Bendig, J., Fanourakis, S., Hobson, B. D., Ramalingam, N., Dettmer, U., Kanter, E., Sulzer, D., & Mosharov, E. V. (2026). α-Synuclein expression is required for somatodendritic dopamine release and immediate early gene induction. Science Advances, 12(5). https://doi.org/10.1126/sciadv.ady6978
Vancouver
Choi SJ, Frank A, Ben-Johny M, Tang G, Bendig J, Fanourakis S, et al. α-Synuclein expression is required for somatodendritic dopamine release and immediate early gene induction. Science Advances. 2026;12(5). doi:10.1126/sciadv.ady6978
BibTeX
@article{Choi2026,
author = {Choi, Se Joon and Frank, Anika and Ben-Johny, Manu and Tang, Guomei and Bendig, Jonas and Fanourakis, Stavros and Hobson, Benjamin D and Ramalingam, Nagendran and Dettmer, Ulf and Kanter, Ellen and Sulzer, David and Mosharov, Eugene V},
title = {α-Synuclein expression is required for somatodendritic dopamine release and immediate early gene induction},
journal = {Science Advances},
year = {2026},
volume = {12},
number = {5},
doi = {10.1126/sciadv.ady6978}
}
EUVIMED